The Long Island Bioscience Hub (LIBH) aims to foster the development of therapeutics, preventatives, diagnostics, devices and research tools emerging from LIBH partner institutions that address diseases within the NIH’s mission.
The development of these technologies is supported by several funding mechanisms as well as a comprehensive suite of technology commercialization services that will help faculty innovators move their academic innovations into the commercial sector via a start-up company, licensing opportunity, and/or a strategic partnership. The Hub focuses its resources on four specific areas:
Expanding existing infrastructure to foster, prioritize, and commercialize innovations across partner institutions.
Implementing translational research initiatives that will accelerate development and create a pipeline of “commercial-ready” innovations.
Recruiting a regional talent pool of experienced Bio-Entrepreneurs in Residence (BEIRs) to facilitate early-stage company formation.
Educating faculty, post-docs, and graduate students about entrepreneurship and commercialization in the life sciences, and establishing a formal mentor network.